The design of orally active iron chelators for the treatment of thalassaemia
Main Author: | Kontoghiorghes, G. |
---|---|
Published: |
University of Essex
1982
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.276026 |
Similar Items
-
Oxidative stress and the glomerulus: influence of prostanoids, angiotensin converting enzyme inhibitors and iron chelation
by: Clayton-Warnes, Lisa J.
Published: (1995) -
The role of transition metal chelation in the control of oxygen activation in the initiation of biological damage
by: Croft, Susan
Published: (1990) -
Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients
by: Shikha Jaiswal, et al.
Published: (2017-02-01) -
Intracellular chelation by ligands from ICRF 159 and its homologues
by: Quinlan, K. M.
Published: (1984) -
In-vitro/in-vivo correlation of the nature of excreted species after chelation therapy with 2,3-dimercaptopropane-1-sulfonic acid
by: Al-Mahasneh, Qusai M.
Published: (2001)